Device Trial Radar · NCT02373852
PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention
Last checked: Nov 21, 2026Latest source record: Sep 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Gardia MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 27, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to collect data on the use of the WIRION system in Patients undergoing Percutaneous Intervention of Saphenous Vein Graft (SVG).
Conditions
- Stenosis
Interventions
Saphenous vein graft (SVG) stentingDevice
Opening and stenting of blocked SVG with the use of the WIRION embolic protection filter
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events During the Procedure and up to 30 Days Following ProcedureTime frame: 30 Days
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bnai Zion
Haifa, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.